EVA REINKE: Open Payments
NPI 1780176578 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 116 payments from 19 companies in 2025. Trend: 2023 $1,377 · 2024 $1,931 · 2025 $2,455
Food & beverage: $2,455
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 19 | $419 |
| GlaxoSmithKline, LLC. | 21 | $369 |
| GENZYME CORPORATION | 7 | $246 |
| AstraZeneca Pharmaceuticals LP | 10 | $242 |
| Verona Pharma, Inc. | 9 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $176 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $131 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Electromed, Inc. | 10 | $103 |
| Lilly USA, LLC | 5 | $90 |
Products named: Arikayce, DUPIXENT, NUCALA, TEZSPIRE, Ohtuvayre, LUMRYZ, OFEV, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
